5. Cepheid (CPHD - Get Report) a molecular diagnostics company, engages in developing, manufacturing and marketing fully-integrated systems for testing in the clinical market, as well as for application in legacy industrial, biothreat and partner markets. Cepheid will report its second quarter 2011 results on July 21 after market.
6 Health Care Stocks to Gain on Earnings
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.